Overweight: Clinical Trials

4 trials for Overweight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 enrolling by invitation. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Enrolling by invitation 4

Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV
Tirzepatide - Human Immunodeficiency Virus (HIV), Metabolic Dysfunction Associated Steatotic Liver Disease
Phase 4Enrolling by invitationNational Taiwan University Clinical Trial Center602026-06-252026-07-20
Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women
semaglutide or tirzepatide, Lifestyle modification intervention - Obesity, Menopause
Phase 4Enrolling by invitationMayo Clinic302025-05-012026-07-20
Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)
early time restricted Mediterranean diet, Mysimba - Diabetes Mellitus, Type 2, Liver Fibrosis
Phase 4Enrolling by invitationCarmen Dietvorst702025-04-142026-04-21
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
Cephalexin, Doxycycline, Cefadroxil - Infections Joint Prosthetic, Overweight or Obesity
Phase 4Enrolling by invitationMayo Clinic46182020-06-112026-07-06

Narrower conditions

Obesity (4)  ·  Diabetes Mellitus (3)  ·  Dyslipidemias (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Autoimmune Diseases (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Fatty Liver (1)  ·  Hypertension (1)  ·  Intermittent Fasting (1)  ·  Liver Cirrhosis (1)  ·  Liver Diseases (1)  ·  Metabolic Syndrome (1)  ·  Renal Insufficiency, Chronic (1)  ·  Tobacco Use (1)

Broader conditions

Body Weight (4)  ·  Nutrition Disorders (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Overnutrition (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Endocrine System Diseases (3)  ·  Glucose Metabolism Disorders (3)  ·  Metabolic Diseases (3)  ·  Behavior (2)  ·  Immune System Diseases (2)  ·  Lipid Metabolism Disorders (2)  ·  Pathologic Processes (2)  ·  Urogenital Diseases (2)  ·  Blood-Borne Infections (1)

Interventions

Tirzepatide (2)  ·  Bupropion (1)  ·  Cefadroxil (1)  ·  Cephalexin (1)  ·  Diet Therapy (1)  ·  Diet, Mediterranean (1)  ·  Doxycycline (1)  ·  Naltrexone (1)  ·  bupropion hydrochloride, naltrexone hydrochoride drug combination (1)  ·  semaglutide (1)

Sponsors

Mayo Clinic (2)  ·  Carmen Dietvorst (1)  ·  National Taiwan University Clinical Trial Center (1)

Countries

United States (2)  ·  Netherlands (1)  ·  Taiwan (1)

Top investigators

Manuel Castro Cabezas, Dr. (1)  ·  Maria D. Hurtado Andrade, M.D., Ph.D. (1)  ·  Nicholas Bedard, MD (1)

Results publications

PMID 42350004